SCHEMBL1004562

SCHEMBL1004562

C#CCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7200821 0.76 MCL1 (0.39)
Urea SCHEMBL9065695 0.71
SCHEMBL233701 0.71
SCHEMBL3950568 0.69
SCHEMBL2017694 0.69 ALDH1A1 (0.40)
SCHEMBL9720 0.69
SCHEMBL17652433 0.69
SCHEMBL5528471 0.69
SCHEMBL8073268 0.69 CYP1A2 (0.35)
SCHEMBL10767020 0.69 CYP1A2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3917907-B1 MODULATORS OF POTASSIUM ION CHANNELS AND USES THEREOF UNIV DEGLI STUDI DI SALERNO (IT) 2025-05-21 EP claimed
EP-4188094-A1 A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF PI Industries Ltd. (IN) 2023-06-07 EP claimed
WO-2022023931-A1 A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF PI INDUSTRIES LTD (IN) 2022-02-03 WO claimed
EP-3749670-B1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIV PALACKEHO (CZ) 2021-10-06 EP claimed
CN-112898317-A Oxazole compound for sterilization and disinfection in hospital care and preparation method and application thereof 河南科技大学第一附属医院 2021-06-04 CN claimed
EP-3108955-B1 SELF-WETTING POROUS MEMBRANES PALL CORP (US) 2017-12-06 EP claimed
EP-2172475-B1 LIPID PEPTIDE FOR USE AS HYDROGEL NISSAN CHEMICAL IND LTD (JP) 2015-06-03 EP claimed
EP-1682520-B1 AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2011-02-23 EP claimed
EP-1891069-A1 2-PHENYL SUBSTITUTED IMIDAZOL [4,5B]PYRIDINE/ PYRAZINE AND PURINE DERIVATIVES AS GLUCOKINASE MODULATORS AstraZeneca AB (SE) 2008-02-27 EP claimed
WO-2006125958-A1 2-PHENYL SUBSTITUTED IMIDAZOL [4 , 5B] PYRIDINE/ PYRAZINE AND PURINE DERIVATIVES AS GLUCOKINASE MODULATORS ASTRAZENECA AB (SE) 2006-11-30 WO claimed
CN-1582281-A MCH receptor antagonists TAISHO PHARMACEUTICAL CO LTD (JP) 2005-02-16 CN claimed
EP-0319986-B1 Anti-plasmin depressant NIPPON SHINYAKU CO LTD (JP) 1997-03-12 EP claimed
EP-0174769-B1 ANTIFUNGAL AZOLE COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-11-21 EP claimed
EP-0094539-B1 HALOGENOPROPARGYL FORMAMIDES BAYER AG (DE) 1985-08-21 EP claimed
EP-0094539-A1 Halogenopropargyl formamides BAYER AG (DE) 1983-11-23 EP claimed
CN-119997985-A Anthracyclines and conjugates thereof 西纳福克斯股份有限公司 2025-05-13 CN disclosed
CN-119233830-A Antibody conjugates for targeting carcinoembryonic antigen-expressing tumors 新锐生物技术公司 2024-12-31 CN disclosed
EP-0094539-B1 HALOGENOPROPARGYL FORMAMIDES BAYER AG (DE) 1985-08-21 EP disclosed
EP-0094539-A1 Halogenopropargyl formamides BAYER AG (DE) 1983-11-23 EP disclosed
EP-0094539-A1 Halogenopropargyl formamides BAYER AG (DE) 1983-11-23 EP disclosed